SCHEMBL4574853

SCHEMBL4574853

Cc1cccc(-c2nc(N(CCCc3cccc(OC(C)(C)C(=O)O)c3)Cc3ccc(C(F)(F)F)cc3)no2)c1

nearest known ligand 0.56

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 19/20 0.56
PPARG P37231 17/20 0.56
PPARD Q03181 10/20 0.56
MDM2 Q00987 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4575330 0.93 PPARA (0.57) PPARAPPARGPPARD
SCHEMBL4575009 0.90 PPARA (0.47) PPARAPPARGPPARD
SCHEMBL4575440 0.90 PPARA (0.52) PPARAPPARGPPARD
SCHEMBL14307863 0.90 PPARA (0.54) PPARAPPARGPPARD
SCHEMBL4574820 0.88 PPARA (0.59) PPARAPPARGPPARD
SCHEMBL4575427 0.88 PPARA (0.54) PPARAPPARGPPARD
SCHEMBL4575460 0.88 PPARA (0.52) PPARAPPARGPPARD
SCHEMBL4575426 0.87 PPARA (0.55) PPARAPPARGPPARD
SCHEMBL4575211 0.86 PPARA (0.59) PPARAPPARGPPARD
SCHEMBL4575961 0.85 PPARA (0.57) PPARAPPARGPPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-7319104-B2 hPPARs activators SMITHKLINE BEECHAM CORPORATION (US) 2008-01-15 US disclosed
US-20050137212-A1 Hppars activators SMITHKLINE BEECHAM CORPORATION 2005-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050137212-A1 Hppars activators PPARG, PPARA, PPARD PPARA 2/4885PPARG 1/4885PPARD 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.